Alzheimer’s disease PSEN-2 N141I mutation reveals altered and shear-sensitive brain endothelial cell-like phenotype in human iPSC-derived models
Open Access
- 11 November 2025
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 13 (1) , 1-16
Abstract
Drug discovery efforts in neurological diseases, such as Alzheimer’s disease (AD), have had particularly poor outcomes due to the lack of models that recapitulate drug interactions at the cerebral vasculature. There is an unmet need to develop physiologically relevant models to study the impacts of blood flow-induced shear stress. In this work, we use a microfluidic platform to model the cerebral vasculature in AD using patient-derived brain endothelial-like cells (BECs). Induced pluripotent stem cells derived from a patient with familial AD (PSEN-2 N141I) and an unaffected control line were differentiated into BECs (AD2-BEC and fControl-BEC, respectively). BECs were exposed to static conditions or 12 dynes/cm 2 of shear stress for 72 h prior to assessment of barrier permeability using fluorescent tracer assays, monocyte adhesion, and efflux transport function using receptor-inhibition assays. Upon shear conditioning, BECs demonstrated shear responsiveness through greater cell alignment in the direction of flow. AD2-BECs demonstrated reduced capacity for efflux transport by p-glycoprotein (P-gp), breast cancer resistant protein (BCRP), and multidrug resistant protein (MRP1) compared to controls (fControl-BECs, p = 0.0017, p = 0.0004, p = 0.0002, respectively). Upon application of shear conditioning, impairments to efflux transport in AD2-BECs were ameliorated. AD2-BECs also exhibited increased monocyte adhesion (2.2 ± 0.4-fold; p < 0.0001) which was further reduced by the application of shear stress in both lines. Taken together, these observations suggest the lack of shear stress exacerbates altered BEC phenotype in fAD. To our knowledge, we present the first in depth functional characterization of in vitro AD patient-derived BECs in both static and physiologically relevant shear conditions in which lack of shear reveals dysfunction of the cerebral endothelium in AD relevant to drug transport and immune cell trafficking.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2022-04375)
This publication has 80 references indexed in Scilit:
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Shear forces induce ICAM-1 nanoclustering on endothelial cells that impact on T-cell migrationBiophysical Journal, 2021
- BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier functionBiomedical Microdevices, 2012
- In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged NeurotoxicityNeurobiology of Disease, 2002
- Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutationJournal of Neuroscience Research, 2001
- Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N141I)Annals of Neurology, 1998
- Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's diseaseVirchows Archiv, 1994
- Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's diseaseJournal of the Neurological Sciences, 1991
- Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 familyNeuroscience Letters, 1989
- Blood flow velocity in capillaries of brain and muscles and its physiological significanceMicrovascular Research, 1981